paclitaxel has been researched along with Idiopathic Parkinson Disease in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amadeo, A; Calogero, AM; Cappelletti, G; Cartelli, D; Casagrande, FVM; Ciammola, A; Costa, I; De Gregorio, C; Gioria, M; Goldwurm, S; Hattori, N; Kuzumaki, N; Okano, H; Pezzoli, G; Roybon, L; Sassone, J | 1 |
| Damascelli, B; Ticha, V | 1 |
| Ahmed, N; Hegde, U; Jabbour, N; Usmani, S | 1 |
| Cappelletti, G; Cartelli, D; Casagrande, F; Goldwurm, S; Pezzoli, G | 1 |
| Feng, J; Ren, Y; Zhao, J | 1 |
| Date, K; Egawa, M; Fujitoh, N; Fujiwara, H; Furukawa, M; Mizunoe, T; Sakashita, T; Ueda, K; Urabe, S; Urabe, T | 1 |
| Feng, J; Jiang, H; Jiang, Q; Liu, W; Ren, Y | 1 |
| Bower, JH; Muenter, MD | 1 |
| Antman, K; Drazen, J; Lagakos, S | 1 |
9 other study(ies) available for paclitaxel and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Parkin absence accelerates microtubule aging in dopaminergic neurons.
Topics: Acetylation; Aging; Animals; Dopaminergic Neurons; Humans; Loss of Function Mutation; Mice, Knockout; Microtubules; Mitochondria; Paclitaxel; Parkinson Disease; PC12 Cells; Rats; Ubiquitin-Protein Ligases | 2018 |
Successful intra-arterial chemotherapy for extramammary Paget's disease of the axilla in a patient with Parkinson's disease.
Topics: Angiography; Antineoplastic Combined Chemotherapy Protocols; Axilla; Biopsy; Doxorubicin; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Nanoparticles; Paclitaxel; Paget Disease, Extramammary; Parkinson Disease; Skin | 2011 |
Acute psychosis after paclitaxel infusion.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Follow-Up Studies; Humans; Infusion Pumps; Laryngeal Neoplasms; Male; Paclitaxel; Parkinson Disease; Psychotic Disorders; Risk Factors | 2011 |
Microtubule destabilization is shared by genetic and idiopathic Parkinson's disease patient fibroblasts.
Topics: Adult; Aged; Female; Fibroblasts; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Male; Microtubules; Middle Aged; Paclitaxel; Parkinson Disease; Phenotype; Phosphorylation | 2012 |
Parkin binds to alpha/beta tubulin and increases their ubiquitination and degradation.
Topics: Animals; Antibody Specificity; Cells, Cultured; Colchicine; Dimerization; Fibroblasts; Humans; Kidney; Ligases; Male; Mice; Microtubule-Associated Proteins; Microtubules; Mutation; Nerve Tissue Proteins; Neuroblastoma; Neurons; Paclitaxel; Parkinson Disease; Protein Binding; Rats; Rats, Sprague-Dawley; Tubulin; Ubiquitin-Protein Ligases; Ubiquitins | 2003 |
[A case of ovarian cancer with Parkinson's disease treated by combined chemotherapy with paclitaxel and carboplatin followed by surgery].
Topics: Adenocarcinoma, Clear Cell; Antineoplastic Combined Chemotherapy Protocols; Antiparkinson Agents; Area Under Curve; Carboplatin; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Hysterectomy; Middle Aged; Ovarian Neoplasms; Ovariectomy; Paclitaxel; Parkinson Disease | 2003 |
Selective vulnerability of dopaminergic neurons to microtubule depolymerization.
Topics: Cell Death; Colchicine; Cytosol; Dopamine; Humans; Microtubules; Nerve Degeneration; Nocodazole; Oxidative Stress; Paclitaxel; Parkinson Disease; Polymers; Receptors, Dopamine; Rotenone; Substantia Nigra; Uncoupling Agents | 2005 |
Temporary worsening of parkinsonism in a patient with Parkinson's disease after treatment with paclitaxel for a metastatic grade IV adenocarcinoma.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Female; Humans; Infusions, Intravenous; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Unknown Primary; Paclitaxel; Parkinson Disease | 1995 |
Designing and funding clinical trials of novel therapies.
Topics: Antineoplastic Agents, Phytogenic; Bone Marrow Transplantation; Breast Neoplasms; Data Interpretation, Statistical; Female; Humans; Insurance, Health; Neurons; Paclitaxel; Parkinson Disease; Randomized Controlled Trials as Topic; Research Design; Research Support as Topic; Sample Size; Survival Analysis; Therapies, Investigational; United States | 2001 |